CD19 and rheumatoid arthritis: Both the MFI of PD-L1 expression and the frequency of CD19+PD-L1+ B cells increased significantly in HC and untreated RA patients upon stimulation (Figure 4E), suggesting that B cells from RA patients can upregulate this inhibitory molecule under appropriate conditions.